Glibenclamide (glyburide)
گلیبنکلامید
🍽️ Alimentary Tract And MetabolismSulfonylurea
Market / country: 🇺🇸 USA
Diabeta (US)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Glyburide · Dosage and Administration
- • Sensitive patients: 1.25 mg. Increase by no more than 2.5 mg weekly; maintenance 1.25–20 mg/day. Above 10 mg/day twice-daily dosing may work better. FDA Glyburide · Dosage and AdministrationFDA Glyburide · Dosage and Administration, Maintenance DoseFDA Glyburide · Dosage and Administration, Dosage Interval
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known hypersensitivity or allergy to the drug (and other items in Contraindications). FDA Glyburide · Contraindications
Warnings
- • Risk of hypoglycaemia; regular meals needed. FDA Glyburide · Dosage and Administration
Formulations
- 1.25 mg tablet (scored) — tablet 🇺🇸 USA FDA Glyburide · How Supplied
- 2.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Glyburide · How Supplied
- 5 mg tablet (scored) — tablet 🇺🇸 USA FDA Glyburide · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Glyburide · Pregnancy
“Teratogenic Effects Pregnancy Category B Reproduction studies have been performed in rats and rabbits at doses up to 500 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to glyburide.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Glyburide · Nursing Mothers
“Because the potential for hypoglycemia in nursing infants may exist, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Glyburide · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Glyburide · Geriatric Use
“Hypoglycemia may be difficult to recognize in the elderly (see PRECAUTIONS ).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA074388
- DailyMed (FDA label)FDA Glyburide
- MedlinePlus (NIH)Glyburide
- WHO ATC/DDDA10BB01
- Darooyab (Iran)Glibenclamide
🇮🇷 Registered in Iran Darooyab · G-625/Glibenclamide
Dosage forms with Iranian generic codes, per Darooyab.
- 00595 · GLIBENCLAMIDE 5MG TAB · قرص گلیبنکلامید ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Glyburide · How SuppliedFDA Glyburide · Dosage and AdministrationFDA Glyburide · Dosage and Administration, Maintenance DoseFDA Glyburide · Dosage and Administration, Dosage IntervalFDA Glyburide · Pediatric UseFDA Glyburide · ContraindicationsFDA Glyburide · PregnancyFDA Glyburide · Nursing MothersFDA Glyburide · Geriatric UseFDA Glyburide · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-625/Glibenclamide
- Clinical review⚠ Unverified